Get the Stockscreener App
1.05
6.06%
0.06
Chimerix Inc stock is traded at $1.05, with a volume of 124.04K.
It is up +6.06% in the last 24 hours and up +14.60% over the past month.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
See More
Previous Close:
$0.99
Open:
$0.97
24h Volume:
124.04K
Relative Volume:
0.29
Market Cap:
$90.98M
Revenue:
$324.00K
Net Income/Loss:
$-82.10M
P/E Ratio:
0.5097
EPS:
2.06
Net Cash Flow:
$-69.18M
1W Performance:
+12.90%
1M Performance:
+14.60%
6M Performance:
+10.19%
1Y Performance:
-0.94%
1-Day Range:
$0.96
$1.05
1-Week Range:
$0.895
$1.05
52-Week Range:
$0.75
$1.30
Chimerix Inc Stock (CMRX) Company Profile
Name
Chimerix Inc
Sector
Industry
Phone
919.806.1074
Address
2505 MERIDIAN PARKWAY, SUITE 100, DURHAM, NC
Chimerix Inc Stock (CMRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-07-22 | Initiated | CapitalOne | Overweight |
| Apr-29-21 | Initiated | Maxim Group | Buy |
| Apr-23-21 | Resumed | Cowen | Outperform |
| Mar-31-21 | Initiated | Jefferies | Buy |
| Mar-31-21 | Initiated | Wedbush | Outperform |
| Feb-14-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Feb-02-18 | Initiated | H.C. Wainwright | Buy |
| Aug-09-16 | Reiterated | FBR Capital | Mkt Perform |
| Feb-23-16 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-23-16 | Reiterated | FBR Capital | Mkt Perform |
| Feb-23-16 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-22-16 | Downgrade | Citigroup | Buy → Neutral |
| Dec-29-15 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-28-15 | Downgrade | FBR Capital | Outperform → Mkt Perform |
| Dec-28-15 | Reiterated | Piper Jaffray | Overweight |
| Dec-17-15 | Initiated | UBS | Buy |
| Oct-05-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-03-15 | Initiated | Citigroup | Buy |
| Aug-18-15 | Initiated | FBR Capital | Outperform |
| Aug-06-15 | Reiterated | Brean Capital | Buy |
| May-11-15 | Reiterated | Brean Capital | Buy |
| Mar-04-15 | Initiated | Barclays | Overweight |
| Feb-12-15 | Reiterated | Stifel | Buy |
| Dec-31-14 | Reiterated | Brean Capital | Buy |
| Jul-08-14 | Resumed | Brean Capital | Buy |
View All
Chimerix Inc Stock (CMRX) Latest News
Chimerix (CMRX) Set to Announce Earnings on Thursday - MarketBeat
Chimerix (NASDAQ:CMRX) Shares Cross Above Two Hundred Day Moving AverageHere's Why - MarketBeat
CMRXChimerix, Inc. Latest Stock News & Market Updates - StockTitan
Chimerix (NASDAQ:CMRX) Stock Price Passes Below 200 Day Moving AverageHere's Why - MarketBeat
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - StockTitan
Chimerix, Inc. (NASDAQ:CMRX) Short Interest Update - MarketBeat
Smallpox Treatment Market to Experience Holistic Expansion - openPR
Chimerix (NASDAQ:CMRX) Share Price Passes Above 200-Day Moving Average – What’s Next? - Defense World
Chimerix (NASDAQ:CMRX) Stock Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Chimerix, Inc. (NASDAQ:CMRX) Shares Sold by Armistice Capital LLC - Defense World
Glioma Market Size was valued ~USD 650 million in 2023 and - openPR
Copart, Inc. (NASDAQ:CPRT) Shares Sold by Xponance Inc. - Defense World
Investor’s Delight: Compass Inc (COMP) Closes Strong at 6.20, Up 0.16 - The Dwinnex
Copart, Inc. (NASDAQ:CPRT) Shares Acquired by Summit Trail Advisors LLC - Defense World
Pacer Advisors Inc. Has $6.38 Million Stock Position in Copart, Inc. (NASDAQ:CPRT) - Defense World
Intech Investment Management LLC Sells 115,103 Shares of C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) - MarketBeat
Providence Capital Advisors LLC Acquires Shares of 61,800 Microchip Technology Incorporated (NASDAQ:MCHP) - MarketBeat
C.H. Robinson Worldwide (NASDAQ:CHRW) Sets New 12-Month High at $105.70 - Defense World
What is COMP’s price-to-sales ratio telling us about the company’s value? - US Post News
Company’s Banking Stock: Dissecting a -38.92% Quarterly Revenue Decline Amid Growth - The InvestChronicle
Investors in cash trouble should check out Cross Country Healthcares, Inc. (CCRN) - SETE News
C.H. Robinson Worldwide Sees Unusually High Options Volume (NASDAQ:CHRW) - MarketBeat
CHRS stock touches 52-week low at $1.01 amid market challenges - Investing.com India
Balance Sheet Insights: Compass Therapeutics Inc (CMPX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Analytical Overview: Coherus Biosciences Inc (CHRS)’s Ratios Tell a Financial Story - The Dwinnex
Davidson Kempner Capital Management LP Acquires Shares of 150,000 C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) - Defense World
Integral Health Asset Management LLC Buys Shares of 275,000 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
A stock that deserves closer examination: Coherus Biosciences Inc (CHRS) - US Post News
Mount Yale Investment Advisors LLC Sells 2,003 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Epoch Investment Partners Inc. Buys 29,098 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Here's Why We're Watching Chimerix's (NASDAQ:CMRX) Cash Burn Situation - Yahoo Finance
Barrow Hanley Mewhinney & Strauss LLC Buys 299,721 Shares of Microchip Technology Incorporated (NASDAQ:MCHP) - Defense World
Revenues Working Against Coherus BioSciences, Inc.'s (NASDAQ:CHRS) Share Price Following 27% Dive - Simply Wall St
Pacer Advisors Inc. Boosts Holdings in Cross Country Healthcare, Inc. (NASDAQ:CCRN) - MarketBeat
Barrow Hanley Mewhinney & Strauss LLC Grows Stake in Microchip Technology Incorporated (NASDAQ:MCHP) - MarketBeat
Mercury Systems, Inc. (MRCY): Street Analysts Are Bearish On This Aviation Stock - Yahoo Finance
Mutual of America Capital Management LLC Cuts Holdings in Copart, Inc. (NASDAQ:CPRT) - Defense World
C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) Shares Purchased by Acadian Asset Management LLC - Defense World
C.H. Robinson Worldwide, Inc. [CHRW] stock for 283,855 USD was sold by Campbell Ben G - Knox Daily
Inspire Investing LLC Lowers Holdings in Copart, Inc. (NASDAQ:CPRT) - Defense World
Bridges Investment Management Inc. Buys 539,300 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Chimerix (NASDAQ:CMRX) Stock Price Crosses Below Two Hundred Day Moving Average of $0.95 - MarketBeat
Railway stock hits 5% upper circuit after receiving order worth ₹ 127.4 Cr for steel sheet piles - Trade Brains
Choreo LLC Purchases New Stake in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) - Defense World
Sienna Gestion Trims Stake in Copart, Inc. (NASDAQ:CPRT) - Defense World
Copart, Inc. (NASDAQ:CPRT) Shares Purchased by Burgundy Asset Management Ltd. - Defense World
Catalyst Pharmaceuticals stock hits 52-week high at $20.88 - Investing.com
E Fund Management Co. Ltd. Increases Stock Position in Copart, Inc. (NASDAQ:CPRT) - Defense World
Waterloo Capital L.P. Purchases 1,517 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Resolute Capital Asset Partners LLC Acquires 10,000 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - MarketBeat
Quest Partners LLC Purchases Shares of 934 Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World
Chimerix Inc Stock (CMRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Chimerix Inc Stock (CMRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Andriole Michael T. | PRESIDENT AND CEO |
Aug 08 '24 |
Sale |
0.83 |
1,285 |
1,065 |
462,453 |
| Andriole Michael T. | PRESIDENT AND CEO |
Feb 14 '24 |
Sale |
1.04 |
1,744 |
1,809 |
447,021 |
| LaSpaluto Michelle | CHIEF FINANCIAL OFFICER |
Feb 14 '24 |
Sale |
1.04 |
1,940 |
2,023 |
110,999 |
| Jakeman David | VP OF FINANCE AND ACCOUNTING |
Feb 14 '24 |
Sale |
1.04 |
2,660 |
2,777 |
141,232 |
| MIDDLETON FRED A | Director |
Nov 17 '23 |
Buy |
0.96 |
17,295 |
16,522 |
100,000 |
| MIDDLETON FRED A | Director |
Nov 10 '23 |
Buy |
0.92 |
2,705 |
2,489 |
82,705 |
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):